Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
Wouter C. Meijers, Antoni Bayés‐Genís, Alexandre Mebazaa, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 10, pp. 1610-1632
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology
Marco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 6, pp. 776-791
Open Access | Times Cited: 101
Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC
Antoni Bayés‐Genís, Kieran F. Docherty, Mark C. Petrie, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 11, pp. 1891-1898
Open Access | Times Cited: 85
The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
Beata Zaborska, Małgorzata Sikora-Frąc, Krzysztof Smarż, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13111-13111
Open Access | Times Cited: 48
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC
Marco Metra, Marianna Adamo, Daniela Tomasoni, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 1115-1131
Open Access | Times Cited: 42
The EAT-Lancet Diet Index, Plasma Proteins, and Risk of Heart Failure in a Population-Based Cohort
Shunming Zhang, Ida Marken, Anna Stubbendorff, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 7, pp. 1197-1208
Open Access | Times Cited: 16
Growth Differentiation Factor–15 Is Associated With Congestion-Related Anorexia and Weight Loss in Advanced Heart Failure
Luca Monzo, Petr Jarolı́m, Barry A. Borlaug, et al.
JACC Heart Failure (2025)
Open Access | Times Cited: 6
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 51
Heart failure: an update from the last years and a look at the near future
Mauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3667-3693
Open Access | Times Cited: 49
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 38
Proteomics of the heart
Oleg A. Karpov, Aleksandr Stotland, Koen Raedschelders, et al.
Physiological Reviews (2024) Vol. 104, Iss. 3, pp. 931-982
Open Access | Times Cited: 13
Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease
Balázs Bence Nyárády, Loretta Kiss, Zsolt Bagyura, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116475-116475
Open Access | Times Cited: 13
Management of cardiogenic shock: state-of-the-art
Christian Jung, Raphael Romano Bruno, Marwan Jumean, et al.
Intensive Care Medicine (2024)
Open Access | Times Cited: 11
Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids
Tao Dong, Wangang Zhu, Zhaochu Yang, et al.
Biosensors and Bioelectronics (2024) Vol. 255, pp. 116090-116090
Closed Access | Times Cited: 10
Recent advances in nanomaterials‐based optical sensors for detection of various biomarkers (inorganic species, organic and biomolecules)
Harshita, Hui‐Fen Wu, Suresh Kumar Kailasa
Luminescence (2022) Vol. 38, Iss. 7, pp. 954-998
Closed Access | Times Cited: 37
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
Antoni Bayés‐Genís, Alberto Aimo, Pardeep S. Jhund, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1767-1777
Open Access | Times Cited: 34
Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity?
Paolo Severino, Andrea D’Amato, Silvia Prosperi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 857-857
Open Access | Times Cited: 32
Detection of myocardial fibrosis: Where we stand
Leyi Zhu, Yining Wang, Shihua Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 28
Guanxining injection alleviates fibrosis in heart failure mice and regulates SLC7A11/GPX4 axis
Chunliu Wang, Jie Zhou, Shixiang Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116367-116367
Closed Access | Times Cited: 18
Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis
Jiangang Jiang, Hongyang Shu, Dao Wen Wang, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 5, pp. 913-939
Closed Access | Times Cited: 6
Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
Mauro Riccardi, Peder L. Myhre, Thomas A. Zelniker, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 11, pp. 468-468
Open Access | Times Cited: 14
Inflammatory response by 48 h after admission and mortality in patients with acute myocardial infarction complicated by cardiogenic shock
Joakim Bo Kunkel, Jakob Josiassen, Ole Kristian Lerche Helgestad, et al.
European Heart Journal Acute Cardiovascular Care (2023) Vol. 12, Iss. 5, pp. 306-314
Closed Access | Times Cited: 13
Biomarkers and Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease
Eva Prescott, K. Bove, Daria Frestad Bechsgaard, et al.
JACC Advances (2023) Vol. 2, Iss. 2, pp. 100264-100264
Open Access | Times Cited: 13
Setting the optimal threshold of NT‐proBNP and BNP for the diagnosis of heart failure in patients over 75 years
Emmanuelle Berthelot, Minh Tam Bailly, Xenia Cerchez Lehova, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 5, pp. 3232-3241
Open Access | Times Cited: 5
From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge
Jialun Zhang, Peining Zhu, Siyu Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease
Alexandra E. Giovou, Monika M Gladka, Vincent M. Christoffels
Cells (2024) Vol. 13, Iss. 11, pp. 931-931
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top